CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.0830
0.00 (0.00%)
Jul 24, 2025, 4:00 PM EDT
CS Diagnostics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
11.40M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
CS Diagnostics News
- 9 days ago - CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC") - Accesswire
- 4 weeks ago - CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th - GlobeNewsWire
- 5 weeks ago - CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT - Accesswire
- 3 months ago - CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS - Accesswire
- 4 months ago - OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval - Accesswire
- 6 months ago - CS Diagnostics Corp. Announces U.S. Launch of MEDUSA - Business Wire